-5%
Seraflo | (Salmeterol Xinafoate + Fluticasone Propionate)
Regular maintenance treatment of asthma in patients:
- Uncontrolled with inhaled corticosteroids plus “as-needed” short-acting β₂-agonist.
- Already controlled on both inhaled corticosteroid and long-acting β₂-agonist.
- Also indicated in COPD for symptom control and prevention of exacerbations.
- Salmeterol: Long-acting (12-hour) β₂-adrenoceptor agonist providing sustained bronchodilation.
- Fluticasone Propionate: Potent inhaled corticosteroid with strong local anti-inflammatory action in the lungs, reducing symptoms and preventing exacerbations.
